JITC Editorial Board - Society for Immunotherapy of Cancer (SITC)
Journal for ImmunoTherapy of Cancer - review Template - BMC
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
Journal for ImmunoTherapy of Cancer on LinkedIn: #jitc
PDF) Nivolumab dose selection: Challenges, opportunities, and lessons learned for cancer immunotherapy
Wei Chen's Paper Publication in the Journal for ImmunoTherapy of Cancer (JITC) - Immunophotonics
PDF) Introducing the society for immunotherapy of cancer's new journal: Journal for immunoTherapy of cancer
Society for Immunotherapy of Cancer on X: "The @sitcancer and @jitcancer are pleased to announce Michael T. Lotze, MD as JITC's Incoming Editor-in-Chief. With over 30 years in the field, Dr. Lotze
Journal for ImmunoTherapy of Cancer - review Template - BMC
Journal for ImmunoTherapy of Cancer | LinkedIn
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
About JITC - Society for Immunotherapy of Cancer (SITC)
JITC Collections and Special Issues - Society for Immunotherapy of Cancer (SITC)
Journal for ImmunoTherapy of Cancer | LinkedIn
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
A new treatment for post-transplant leukemia relapse! A study by José Cohen's I-BIOT team published this month in the Journal for Immunotherapy of cancer | IMRB – Mondor Biomedical Research Institute
Journal for ImmunoTherapy of Cancer (@jitcancer) / X
Journal for ImmunoTherapy of Cancer | LinkedIn
PDF) Moving cancer immunotherapy forward through the Journal for ImmunoTherapy of Cancer (JITC)
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells - Immunomodulation Lab
Join us in congratulating Incoming Editor-in-Chief Michael Lotze and Deputy Editor-in-Chief Sjoerd van der Burg - Journal for ImmunoTherapy of Cancer - OncoDaily
Journal for ImmunoTherapy of Cancer (JITC) - YouTube
Journal for ImmunoTherapy of Cancer
